TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
PRPO

Precipio Inc

Healthcare · Diagnostics & Research

22.30$ -1.5% vs. previous close Closing price · As of: Oct 14, 2026

Statements

Segments

US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Precipio Inc (PRPO). It shows which part of the business is growing — and which one is holding it back.

Revenue by business segment

Revenue by business segment — PRPO
Segment 2023 2024 2025
Single reportable segment FBQ15.2M 100.0% FBQ18.5M 100.0% · +21.9% FBQ24.0M 100.0% · +29.8%

Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.

Revenue by product line

Revenue by product line — PRPO
Segment 2021 2022 2023 2024 2025
Service revenue, net ANA7.8M 89.5% ANA8.4M 85.7% · +8.2% ANA12.4M 80.4% · +47.3% ANA16.0M 85.9% · +28.8% ANA21.5M 88.7% · +34.7%
Product revenue – – ANA3.0M 19.6% ANA2.6M 14.1% · -13.5% ANA2.7M 11.3% · +4.9%
Other ANA914.0K 10.5% ANA1.4M 14.3% · +53.4% – – –

Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.

Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.

Data as of: October 14, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?